However, HULC plus PTEN did significantly not alter the BrdU positive rate of liver cancer cells (32.37 ± 9.68% versus 25.59. ± 6.04%, p = 0.1966 > 0.05) (Fig. 9c). The gene discussed is PTEN; the disease is liver cancer.